Abstract
Background: A recent systematic review identified only two prediction models for survival in resectable pancreatic cancer of high methodological quality. The objective of this study was to validate one of these, the Amsterdam prediction model (including differentiation grade, positive lymph node ratio, margin status and adjuvant therapy), in a large international cohort. Methods: All consecutive patients who underwent pancreatoduodenectomy for pancreatic cancer between 2000-2017 at 10 tertiary hospitals from 8 countries were included. Calibration and model performance for prediction of 3-year and 5-year survival were evaluated and compared to the 8th edition of the TNM staging system, using Uno’s C-statistic, the Receiver Operating Characteristics (ROC) curves and area under the curves (AUC). Results: A total of 2,203 patients were included (mean age 65 years, 54% male), with a median overall survival of 23.6 months. The validation cohort was demographically comparable to the design cohort, but had a higher lymph node yield (median of 19 vs. 8) and more N2 disease (22.0% vs. 40.3%), and a higher use of adjuvant therapy (76.0% vs. 35.1%). Calibration analysis demonstrated that the predictions of 3-year survival did not systematically deviate from the observed survival rates with a slope of 0.85 and an intercept of 0.04. Uno’s C-statistic was 0.65 in the validation cohort, compared to 0.67 in the derivation cohort. ROC-curves showed an AUC of 0.70 and 0.72 for 3- and 5-year survival, compared to 0.65 and 0.68 for the TNM 8, respectively. Analysis of model performance among the different countries demonstrated a robust C-statistic, ranging from 0.61 to 0.67. Conclusions: This international multicenter study validated the previous predictions of the Amsterdam model for 3- and 5-year survival after pancreatoduodenectomy for pancreatic cancer. Model performance was fairly accurate in terms of calibration and discrimination, and the model demonstrated robustness within the different countries.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.